Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rakovina Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rakovina Therapeutics Inc market cap is $6.95M.
What is the 52-week high for Rakovina Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rakovina Therapeutics Inc 52 week high is $100.00 as of September 06, 2025.
What is the 52-week low for Rakovina Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rakovina Therapeutics Inc 52 week low is $0.289 as of September 06, 2025.
What is Rakovina Therapeutics Inc stock price today?
Rakovina Therapeutics Inc stock price today is $0.3149.
What was Rakovina Therapeutics Inc stock price yesterday?
Rakovina Therapeutics Inc stock price yesterday was $0.3288.
What is the PE ratio of Rakovina Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rakovina Therapeutics Inc’s P/E ratio is -0.77.
What is the Price-to-Book ratio of Rakovina Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rakovina Therapeutics Inc P/B ratio is 2.8829.
What is the 50-day moving average of Rakovina Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rakovina Therapeutics Inc 50-day moving average is $0.4377.
